Apoptosis is induced in leishmanial cells by a novel protein kinase inhibitor withaferin A and is facilitated by apoptotic topoisomerase I-DNA complex

Cell Death Differ. 2007 Feb;14(2):358-67. doi: 10.1038/sj.cdd.4402002. Epub 2006 Jul 14.

Abstract

Protein kinase C (PKC) is an important constituent of the signaling pathways involved in apoptosis. We report here that like staurosporine, withaferin A is a potent inhibitor of PKC. In Leishmania donovani, the inhibition of PKC by withaferin A causes depolarization of DeltaPsim and generates ROS inside cells. Loss of DeltaPsim leads to the release of cytochrome c into the cytosol and subsequently activates caspase-like proteases and oligonucleosomal DNA cleavage. Moreover, in treated cells, oxidative DNA lesions facilitate the stabilization of topoisomerase I-mediated cleavable complexes, which also contribute to DNA fragmentation. However, withaferin A and staurosporine cannot induce cleavable complex formation in vitro with recombinant topoisomerase I nor with nuclear extracts from control cells. Taken together, our results indicate that inhibition of PKC by withaferin A is a central event for the induction of apoptosis and that the stabilization of topoisomerase I-DNA complex is necessary to amplify apoptotic process.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Caspases / metabolism
  • Catalysis / drug effects
  • Cytochromes c / metabolism
  • Cytosol / drug effects
  • DNA Cleavage / drug effects
  • DNA Fragmentation / drug effects
  • DNA Topoisomerases, Type I / metabolism*
  • DNA, Protozoan / metabolism*
  • Enzyme Activation / drug effects
  • Ergosterol / analogs & derivatives*
  • Ergosterol / chemistry
  • Ergosterol / pharmacology
  • Glutathione / metabolism
  • Leishmania donovani / cytology*
  • Leishmania donovani / drug effects*
  • Leishmania donovani / enzymology
  • Membrane Potential, Mitochondrial / drug effects
  • Oxidative Stress / drug effects
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase Inhibitors / chemistry
  • Protein Kinase Inhibitors / pharmacology*
  • Reactive Oxygen Species / metabolism
  • Staurosporine / chemistry
  • Staurosporine / pharmacology
  • Withanolides

Substances

  • DNA, Protozoan
  • Protein Kinase Inhibitors
  • Reactive Oxygen Species
  • Withanolides
  • Cytochromes c
  • Protein Kinase C
  • Caspases
  • DNA Topoisomerases, Type I
  • Glutathione
  • Staurosporine
  • withaferin A
  • Ergosterol